If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...

Importers and consumers, then, are likely to bear the brunt. The Yale Budget Lab estimates tariffs could add US$2,400 ...